Athira Pharma Public
Athira Pharma is a clinical-stage drug development company that focuses on biotechnology and pharmaceuticals. Their main goal is to improve human health by developing innovative therapies for brain disorders. They specialize in small molecule compounds that promote regeneration, provide neuroprotection, and potentially modify neurodegenerative diseases. Athira Pharma is committed to advancing bold and impactful therapies that can positively impact everyone.
Technology:
Cancer
Headquarters:
Seattle, Washington, United States
Funding Status:
IPO
Founded Date:
2011
Last Funding Type:
Post-IPO Equity
Investors Number:
26
Last Funding Date:
2021
Estimated Revenue:
$1M to $10M
Employee Number:
11-50
Total Funding:
233600000
Industry:
PharmTech
Investor Type:
IPO